HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|33|3839-3843

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.33, 2009-11, pp. : 3839-3843

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIF Inhibitors: New Hope for Cancer Therapy

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 9, 2015-01 ,pp. : 736-753

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 4, 2018-01 ,pp. : 296-309

Bentham Science Publishers

Access to resources Recommend Favorite

Drug discovery using the regulation of gene expression

By St-Pierre Yves  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 7, 2007-07 ,pp. : 987-1000

Informa Healthcare

Access to resources Recommend Favorite

Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-06 ,pp. : 1166-1176

Bentham Science Publishers

Access to resources Recommend Favorite

Genomics Strategies for Antifungal Drug Discovery - From Gene Discovery to Compound Screening

By  

Current Pharmaceutical Design, Vol. 8, Iss. 13, 2002-06 ,pp. : 1137-1154

Bentham Science Publishers

Access to resources Recommend Favorite